Prostate-specific antigen (PSA) testing may not accurately pinpoint levels at which transgender women on estrogen therapy may be at risk of developing prostate cancer, according to data from the ...

Please provide your email address to receive an email when new articles are posted on . Transgender women were significantly less likely to receive a PSA screening vs. cisgender men. A clinician’s ...

Transgender women on hormone therapy tend to skew artificially low on prostate cancer screening tests, which may give false reassurance and delay diagnosis and treatment, reports a new study led by UC ...

Prostate cancer is the second-leading cause of cancer-associated death in men after lung cancer. Prostate cancer is highly common in which 1 in 8 men will be diagnosed with the disease in their ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Aria F. Olumi, MD: ...

Add Yahoo as a preferred source to see more of our stories on Google. Joe Biden alongside group of queer people transgender women gay men people with prostates On Sunday, a short statement from the ...

In a recent study, PSA level was undetectable in 36% of transgender individuals receiving estrogen. (HealthDay News) — For transgender individuals receiving estrogen, the median prostate-specific ...

Transgender women are still at risk for prostate cancer. A new study led by Cedars-Sinai Cancer investigators, published in the peer-reviewed Journal of the American Medical Association, concludes ...

PARIS — Screening for breast, cervical, and prostate cancer should continue for transgender patients after they transition to their new identity, but the screening methods must be adapted. This was ...

UCSF-led study alerts transwomen and physicians to interpret standard screening guidelines with caution. Transgender women on hormone therapy tend to skew artificially low on prostate cancer screening ...